Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SPEISER W' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 72 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Exner, M; Hermann, M; Hofbauer, R; Kapiotis, S; Quehenberger, P; Speiser, W; Held, I; Gmeiner, BMK
      Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein

      FREE RADICAL RESEARCH
    2. Speiser, W; Kapiotis, S; Kopp, CW; Simonitsch, I; Jilma, B; Jansen, B; Exner, M; Chott, A
      Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium - An in vivo study of human skin biopsies

      THROMBOSIS AND HAEMOSTASIS
    3. Apsner, R; Buchmayer, H; Lang, T; Unver, B; Speiser, W; Sunder-Plassmann, G; Horl, WH
      Simplified citrate anticoagulation for high-flux hemodialysis

      AMERICAN JOURNAL OF KIDNEY DISEASES
    4. Pernerstorfer, T; Eichler, HG; Stohlawetz, P; Speiser, W; Jilma, B
      Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand Factor levels in healthy men

      ATHEROSCLEROSIS
    5. Exner, M; Alt, E; Hermann, M; Hofbauer, R; Kapiotis, S; Quehenberger, P; Speiser, W; Minar, E; Gmeiner, B
      p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL

      FEBS LETTERS
    6. Exner, M; Hermann, M; Hofbauer, R; Kapiotis, S; Quehenberger, P; Speiser, W; Held, I; Gmeiner, BMK
      Semicarbazide-sensitive amine oxidase catalyzes endothelial cell-mediated low density lipoprotein oxidation

      CARDIOVASCULAR RESEARCH
    7. Quehenberger, P; Handler, S; Mannhalter, C; Pabinger-Fasching, I; Speiser, W
      Evaluation of a highly specific functional test for the detection of factor V Leiden

      INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    8. Schwarzinger, I; Speiser, W; Lubenow, N; Greinacher, A; Panzer, S
      Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: Coincidence or association?

      THROMBOSIS AND HAEMOSTASIS
    9. Homoncik, M; Jilma, B; Hergovich, N; Stohlawetz, P; Panzer, S; Speiser, W
      Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100 (R)

      THROMBOSIS AND HAEMOSTASIS
    10. Male, C; Lechner, K; Speiser, W; Pabinger, I
      Transient lupus anticoagulants in children: Stepwise disappearance of diagnostic features

      THROMBOSIS AND HAEMOSTASIS
    11. Hofbauer, R; Moser, D; Kaye, AD; Dielacher, C; Hornykewycz, S; Handler, S; Speiser, W; Kapiotis, S; Frass, M
      Thrombus formation on the balloon of heparin-bonded pulmonary artery catheters: An ultrastructural scanning electron microscope study

      CRITICAL CARE MEDICINE
    12. Kyrle, PA; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Schneider, B; Weltermann, A; Speiser, W; Lechner, K; Eichinger, S
      High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.

      NEW ENGLAND JOURNAL OF MEDICINE
    13. Exner, M; Hermann, M; Hofbauer, R; Kapiotis, S; Speiser, W; Held, I; Seelos, C; Gmeiner, BMK
      The salicylate metabolite gentisic acid, but not the parent drug, inhibitsglucose autoxidation-mediated atherogenic modification of low density lipoprotein

      FEBS LETTERS
    14. Quehenberger, P; Bierhaus, A; Fasching, P; Muellner, C; Klevesath, M; Hong, M; Stier, G; Sattler, M; Schleicher, E; Speiser, W; Nawroth, PP
      Endothelin 1 transcription is controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells

      DIABETES
    15. Pernerstorfer, T; Hollenstein, U; Hansen, JB; Stohlawetz, P; Eichler, HG; Handler, S; Speiser, W; Jilma, B
      Lepirudin blunts endotoxin-induced coagulation activation

      BLOOD
    16. Pernerstorfer, T; Stohlawetz, P; Hollenstein, U; Dzirlo, L; Eichler, HG; Kapiotis, S; Jilma, B; Speiser, W
      Endotoxin-induced activation of the coagulation cascade in humans - Effectof acetylsalicylic acid and acetaminophen

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    17. Quehenberger, P; Handler, S; Mannhalter, C; Kyrle, PA; Speiser, W
      The Factor V (Leiden) Test: Evaluation of an assay based on dilute RussellViper Venom Time for the detection of the Factor V Leiden mutation

      THROMBOSIS RESEARCH
    18. Quehenberger, P; Kapiotis, S; Handler, S; Ruzicka, K; Speiser, W
      Evaluation of the automated coagulation analyzer SYSMEX CA 6000

      THROMBOSIS RESEARCH
    19. Hofbauer, R; Frass, M; Gmeiner, B; Handler, S; Speiser, W; Kapiotis, S
      The green tea extract epigallocatechin gallate is able to reduce neutrophil transmigration through monolayers of endothelial cells

      WIENER KLINISCHE WOCHENSCHRIFT
    20. Hofbauer, R; Frass, M; Gmeiner, B; Speiser, W; Wagner, O; Kapiotis, S
      Rapid, fluorescence-based assay for microtiter plates to test drug influences on neutrophil transmigration through endothelial cell monolayers

      LIFE SCIENCES
    21. Hofbauer, R; Gmeiner, B; Handler, S; Speiser, W; Kapiotis, S; Frass, M
      Dexamethasone inhibits leukocyte migration through endothelial cells towards smooth muscle cells

      LIFE SCIENCES
    22. Sillalber, C; Baghestanian, M; Bevec, D; Willheim, M; Agis, H; Kapiotis, S; Fureder, W; Bankl, HC; Kiener, HP; Speiser, W; Binder, BR; Lechner, K; Valent, P
      The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis

      JOURNAL OF IMMUNOLOGY
    23. Pernerstorfer, T; Hollenstein, U; Hansen, JB; Knechtelsdorfer, M; Stohlawetz, P; Graninger, W; Eichler, HG; Speiser, W; Jilma, B
      Heparin blunts endotoxin-induced coagulation activation

      CIRCULATION
    24. Pernerstorfer, T; Jilma, B; Eichler, HG; Aull, S; Handler, S; Speiser, W
      Heparin lowers plasma levels of activated factor VII

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Novacek, G; Miehsler, W; Kapiotis, S; Katzenschlager, R; Speiser, W; Vogelsang, H
      Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    26. KYRLE PA; MANNHALTER C; BEGUIN S; STUMPFLEN A; HIRSCHL M; WELTERMANN A; STAIN M; BRENNER B; SPEISER W; PABINGER I; LECHNER K; EICHINGER S
      CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE

      Arteriosclerosis, thrombosis, and vascular biology
    27. HELLAN M; KUHNEL E; SPEISER W; LECHNER K; EICHINGER S
      FAMILIAL LUPUS ANTICOAGULANT - A CASE-REPORT AND REVIEW OF THE LITERATURE

      Blood coagulation & fibrinolysis
    28. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    29. KAPIOTIS S; JILMA B; PERNERSTORFER T; STOHLAWETZ P; EICHLER HG; SPEISER W
      PLASMA-LEVELS OF ACTIVATED FACTOR-VII DECREASE DURING THE MENSTRUAL-CYCLE

      Thrombosis and haemostasis
    30. KOZEKLANGENECKER SA; KETTNER SC; OISMUELLER C; GONANO C; SPEISER W; ZIMPFER M
      ANTICOAGULATION WITH PROSTAGLANDIN E-1 AND UNFRACTIONATED HEPARIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Critical care medicine
    31. WELTERMANN A; MITTERBAUER GJ; MITTERBAUER M; HATTEY E; SPEISER W; GISSLINGER H; KNOBL P; EICHINGER S
      DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)

      Wiener Klinische Wochenschrift
    32. HOFBAUER R; HOFBAUER L; MOSER D; SALFINGER H; SPEISER W; FRASS M; KAPIOTIS S
      LEUKOCYTE MIGRATION - A NEW TRIPLE MIGRATION CHAMBER ASSAY ALLOWS INVESTIGATION OF VARIOUS CELL-INTERACTIONS SIMULTANEOUSLY

      Life sciences (1973)
    33. RUZICKA K; WOJTA J; ARTEMIOU O; BIRSAN T; QUEHENBERGER P; KAPIOTIS S; HOFBAUER R; SPEISER W
      HUMAN ENDOTHELIAL-CELLS DO NOT EXERT HEPARIN-LIKE ACCELERATING EFFECTS ON THROMBIN-ANTITHROMBIN-COMPLEX FORMATION

      Life sciences (1973)
    34. HOFBAUER R; SPEISER W; KAPIOTIS S
      IBUPROFEN INHIBITS LEUKOCYTE MIGRATION THROUGH ENDOTHELIAL-CELL MONOLAYERS

      Life sciences
    35. QUEHENBERGER P; BIERHAUS A; FASCHING P; SPEISER W; NAWROTH PP
      INCREASED ENDOTHELIN-1 LEVELS THROUGH INTERACTION OF RED-BLOOD-CELLS WITH ENDOTHELIAL-CELLS

      British Journal of Haematology
    36. QUEHENBERGER P; LONER U; KAPIOTIS S; HANDLER S; SCHNEIDER B; HUBER J; SPEISER W
      EFFECTS OF 3RD-GENERATION ORAL-CONTRACEPTIVES CONTAINING NEWLY DEVELOPED PROGESTAGENS ON FIBRINOLYTIC PARAMETERS

      Fibrinolysis & proteolysis
    37. KAPIOTIS S; JILMA B; SZALAY T; DIRNBERGER E; WAGNER O; EICHLER HG; SPEISER W
      EVIDENCE AGAINST AN EFFECT OF ENDOTHELIN-1 ON BLOOD-COAGULATION, FIBRINOLYSIS, AND ENDOTHELIAL-CELL INTEGRITY IN HEALTHY-MEN

      Arteriosclerosis, thrombosis, and vascular biology
    38. NOVACEK G; KAPIOTIS S; MOSER G; SPEISER W; GANGL A; VOGELSANG H
      NO EVIDENCE OF ACTIVATED BLOOD-COAGULATION IN CROHNS-DISEASE

      European journal of gastroenterology & hepatology
    39. KYRLE PA; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; SPEISER W; WELTERMANN A; KAIDER A; PABINGER I; LECHNER K; EICHINGER S
      LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    40. JILMA B; DIRNBERGER E; EICHLER HG; MATULLA B; SCHMETTERER L; KAPIOTIS S; SPEISER W; WAGNER OF
      PARTIAL BLOCKADE OF NITRIC-OXIDE SYNTHASE BLUNTS THE EXERCISE-INDUCEDINCREASE OF VON-WILLEBRAND-FACTOR ANTIGEN AND OF FACTOR-VIII IN MAN

      Thrombosis and haemostasis
    41. KYRLE PA; EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; SCHNEIDER B; MANNHALTER C; MELICHART M; TRAXLER G; WELTERMANN A; SPEISER W; LECHNER K
      PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    42. KYRLE PA; BROCKMEIER J; WELTERMANN A; EICHINGER S; SPEISER W; LECHNER K; EICHLER HG
      INHIBITION RATHER THAN ENHANCEMENT OF HEMOSTATIC SYSTEM ACTIVATION DURING INITIATION OF ORAL ANTICOAGULANT TREATMENT

      Thrombosis and haemostasis
    43. QUEHENBERGER P; BIERHAUS A; FASCHING P; MULLNER C; SPEISER W; ZIEGLER R; NAWROTH PP
      INDUCTION OF ENDOTHELIN-1 THROUGH ERYTHROCYTES OF PATIENTS WITH DIABETES-MELLITUS

      Thrombosis and haemostasis
    44. KYRLE PA; EICHINGER S; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; PABINGER I; SPEISER W; SCHNEIDER B; LECHNER K
      HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS WITH HYPERHOMOCYSTEINEMIA (H-HC)

      Thrombosis and haemostasis
    45. NOVACEK G; KAPIOTIS S; JILMA B; QUEHENBERGER P; MICHITSCH A; TRAINDL O; SPEISER W
      ENHANCED BLOOD-COAGULATION AND ENHANCED FIBRINOLYSIS DURING HEMODIALYSIS WITH PROSTACYCLIN

      Thrombosis research
    46. RUZICKA K; KAPIOTIS S; QUEHENBERGER P; HANDLER S; PABINGERFASCHING I; MANNHALTER C; JILMA B; SPEISER W
      EVALUATION OF A NEW SCREENING ASSAY PROC(R) GLOBAL FOR IDENTIFICATIONOF DEFECTS IN THE PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY

      Thrombosis research
    47. RUZICKA K; KAPIOTIS S; QUEHENBERGER P; HANDLER S; HORNYKEWYCZ S; MICHITSCH A; HUBER K; CLEMENS D; SUSAN M; PABINGER I; EICHINGER S; JILMA B; SPEISER W
      EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS

      Thrombosis research
    48. KAPIOTIS S; JILMA B; QUEHENBERGER P; RUZICKA K; HANDLER S; SPEISER W
      MORNING HYPERCOAGULABILITY AND HYPOFIBRINOLYSIS - DIURNAL-VARIATIONS IN CIRCULATING ACTIVATED FACTOR-VII, PROTHROMBIN FRAGMENT F1-PLASMIN INHIBITOR-COMPLEX(2, AND PLASMIN)

      Atherosclerosis
    49. KAPIOTIS S; JILMA B; QUEHENBERGER P; RUZICKA K; HANDLER S; SPEISER W
      MORNING HYPERCOAGULABILITY AND HYPOFIBRINOLYSIS - DIURNAL-VARIATIONS IN CIRCULATING ACTIVATED FACTOR-VII, PROTHROMBIN FRAGMENT F1-PLASMIN INHIBITOR COMPLEX(2, AND PLASMIN)

      Circulation
    50. JILMA B; EICHLER HG; STOHLAWETZ P; PERNERSTORFER T; SPEISER W; KAPIOTIS S; KALHS P
      PARTIAL BLOCKADE OF NITRIC-OXIDE SYNTHASE BLUNTS THE EXERCISE-INDUCEDINCREASE OF VON-WILLEBRAND-FACTOR ANTIGEN AND OF FACTOR-VIII IN MAN

      Blood
    51. QUEHENBERGER P; LONER U; KAPIOTIS S; HANDLER S; SCHNEIDER B; HUBER J; SPEISER W
      INCREASED LEVELS OF ACTIVATED FACTOR-VII AND DECREASED PLASMA-PROTEINS-ACTIVITY AND CIRCULATING THROMBOMODULIN DURING USE OF ORAL-CONTRACEPTIVES

      Thrombosis and haemostasis
    52. KAPIOTIS S; SENGOELGE G; SPERR WR; BAGHESTANIAN M; QUEHENBERGER P; BEVEC D; LI SR; MENZEL EJ; MUHL A; ZAPOLSKA D; VIRGOLINI I; VALENT P; SPEISER W
      IBUPROFEN INHIBITS PYROGEN-DEPENDENT EXPRESSION OF VCAM-1 AND ICAM-1 ON HUMAN ENDOTHELIAL-CELLS

      Life sciences
    53. JILMA B; EICHLER HG; VONDROVEC B; BREITENEDER H; KYRLE PA; KITZWEGER E; KAPIOTIS S; SPEISER W
      EFFECTS OF DESMOPRESSIN ON CIRCULATING P-SELECTIN

      British Journal of Haematology
    54. SITZWOHL C; KOZEK S; KAPIOTIS S; SPEISER W; SPISS CK; ILLIEVICH UM
      EFFECT OF GRADED HYPOTHERMIA (36-DEGREES-C-32-DEGREES-C) ON BASAL ACTIVITY OF THE COAGULATION AND FIBRINOLYTIC SYSTEM

      Anesthesiology
    55. KAPIOTIS S; QUEHENBERGER P; JILMA B; HANDLER S; PABINGERFASCHING I; MANNHALTER C; SPEISER W
      IMPROVED CHARACTERISTICS OF APC-RESISTANCE ASSAY - COATEST APC RESISTANCE BY PREDILUTION OF SAMPLES WITH FACTOR-V DEFICIENT PLASMA

      American journal of clinical pathology
    56. QUEHENBERGER P; GRETEN J; RIEDESEL JV; ZIEGLER R; WAHL P; SPEISER W; BIERHAUS A; NAWROTH PP
      INDUCTION OF ENDOTHELIN-1 BY ADVANCED GLYCATION ENDPRODUCTS IN CULTURED BOVINE ENDOTHELIAL-CELLS

      Thrombosis and haemostasis
    57. BAGHESTANIAN M; SILLABER C; BEVEC D; WILLHEIM M; RADASZKIEWICZ T; AGIS H; MULLER MR; FUREDER W; BANKL HC; KAPIOTIS S; SPEISER W; BINDER BR; LECHNER L; VALENT P
      MAST-CELLS EXPRESS TPA ANTIGEN AND ARE A UNIQUE SOURCE OF PROFIBRINOLYTIC ACTIVITY

      Thrombosis and haemostasis
    58. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIENDOBERSBERGER T; TRIBL B; SPEISER W; DRUML W; PABINGER I; LECHNER K
      ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS

      Thrombosis and haemostasis
    59. BAGHESTANIAN M; SILLABER C; BEVEC D; FUREDER W; AGIS H; MULLER MR; WILLHEIM M; KAPIOTIS S; SPEISER W; BETTELHEIM P; LECHNER K; VALENT P
      EXPRESSION OF PRO-FIBRINOLYTIC ACTIVITY, A HIGH TPA PAI RATIO AND UPAR/CD87 IN HUMAN MAST-CELLS/

      Experimental hematology
    60. KAPIOTIS S; QUEHENBERGER P; SPEISER W
      EVALUATION OF THE NEW METHOD COAGUCHEK(R) FOR THE DETERMINATION OF PROTHROMBIN TIME FROM CAPILLARY BLOOD - COMPARISON WITH THROMBOTEST(R) ON KC-1

      Thrombosis research
    61. FODINGER M; SPEISER W; KARABENTCHEVA S; SCHERRER R; VEITL M; SCHWARZINGER I
      EVALUATION OF A TOTAL HEMATOLOGY ANALYSIS SYSTEM (SYSMEX HS-430) - BENEFITS FOR LARGE LABORATORIES BY REDUCING MANUAL WORK LOAD AND OPTIMIZING SCREENING EFFICACY FOR PATHOLOGICAL SAMPLES

      American journal of clinical pathology
    62. KAPIOTIS S; QUEHENBERGER P; SENGOELGE G; PARTAN C; EHER R; STROBL H; BEVEC D; ZAPOLSKA D; SCHWARZINGER I; SPEISER W
      MODULATION OF PYROGEN-INDUCED UP-REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES (CAMS) BY INTERLEUKIN-4 - TRANSCRIPTIONAL MECHANISMS ANDCAM-SHEDDING

      Circulatory shock
    63. KAPIOTIS S; QUEHENBERGER P; EICHLER HG; SCHWARZINGER I; PARTAN C; SCHNEIDER B; LECHNER K; SPEISER W
      EFFECT OF HYDROXYETHYL STARCH ON THE ACTIVITY OF BLOOD-COAGULATION AND FIBRINOLYSIS IN HEALTHY-VOLUNTEERS - COMPARISON WITH ALBUMIN

      Critical care medicine
    64. BAGHESTANIAN M; SILLABER C; BEVEC D; FUREDER W; AGIS H; MULLER MR; WILLHEIM M; RAIDL M; KAPIOTIS S; SPEISER W; BETTELHEIM P; LECHNER K; VALENT P
      EXPRESSION OF PRO-FIBRINOLYTIC ACTIVITY, A HIGH TPA PAI RATIO AND UPAR/CD87 IN HUMAN MAST-CELLS/

      Blood
    65. KAPIOTIS S; SENGOELGE G; QUEHENBERGER P; BAGHESTANIAN M; BEVEC D; VALENT P; SPEISER W
      DICLOFENAC INHIBITS LIPOPOLYSACCHARIDE-DEPENDENT EXPRESSION OF TISSUEFACTOR IN HUMAN ENDOTHELIAL-CELLS AND MONOCYTES

      Blood
    66. KAPIOTIS S; SENGOELGE G; SPERR WR; BAGHESTANIAN M; LI SR; QUEHENBERGER P; BEVEC D; MENZEL EJ; MUHL A; VIRGOLINI I; VALENT P; SPEISER W
      IBUPROFEN INHIBITS IL-1 ALPHA-DEPENDENT AND TNF ALPHA-DEPENDENT EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1 CD106) AND INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1 CD54) ON HUMAN ENDOTHELIAL-CELLS

      Blood
    67. SCHWARZINGER I; FODINGER M; SCHERRER R; WOLZT M; MANNHALTER C; SPEISER W
      HYPERGRANULAR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - REPORT OF A CASE AND REVIEW OF THE LITERATURE

      Annals of hematology
    68. IHNKEN K; SPEISER W; RUF W; THIEL W; SCHLEPPER M; MULLERBERGHAUS G
      HIGH PAI ACTIVITY WITH CORRELATION TO TRIGLYCERIDE AND HDL CHOLESTEROL VALUES IN PATIENTS WITH CORONARY-ARTERY DISEASE WITH NO DIFFERENCE IN SURVIVORS OF MYOCARDIAL-INFARCTION

      Annals of hematology
    69. QUEHENBERGER P; KAPIOTIS S; PARTAN C; SCHNEIDER B; WENZEL R; GAIGER A; SPEISER W
      STUDIES ON ORAL CONTRACEPTIVE-INDUCED CHANGES IN BLOOD-COAGULATION AND FIBRINOLYSIS AND THE ESTROGEN EFFECT ON ENDOTHELIAL-CELLS

      Annals of hematology
    70. QUEHENBERGER P; KAPIOTIS S; SENGOELGE G; PARTAN C; SPEISER W
      STUDIES ON THE EFFECTS OF A LOW ESTROGEN PILL ON BLOOD-COAGULATION AND FIBRINOLYTIC PARAMETERS

      Thrombosis and haemostasis
    71. KNOBL P; KAPIOTIS S; LACZIKA K; JAGER U; KYRLE A; SPEISER W; LECHNER K
      ATTENUATION OF THE HEMOSTATIC DISORDER IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID

      Thrombosis and haemostasis
    72. KAPIOTIS S; SENGOELGE G; QUEHENBERGER P; FOSTER CA; VIRGOLINI I; VALENT P; SPEISER W
      IBUPROFEN INHIBITS PYROGEN-INDUCED EXPRESSION OF VCAM-1 AND BINDING OF PBMNC ON VASCULAR ENDOTHELIAL-CELLS

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 12:52:45